Dr. Mehmet S. Copur

Claim this profile

Bethesda North Hospital

Studies Breast Cancer
Studies Fallopian Tube Carcinoma
3 reported clinical trials
14 drugs studied

Area of expertise

1Breast Cancer
Mehmet S. Copur has run 2 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
HER2 positive
ER negative
2Fallopian Tube Carcinoma
Mehmet S. Copur has run 1 trial for Fallopian Tube Carcinoma. Some of their research focus areas include:
Stage III
Stage II
Stage IV

Affiliated Hospitals

Image of trial facility.
Bethesda North Hospital
Image of trial facility.
Saint Mary Corwin Medical Center

Clinical Trials Mehmet S. Copur is currently running

Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

More about Mehmet S. Copur

Clinical Trial Related12 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mehmet S. Copur has experience with
  • Regional Nodal XRT
  • Chestwall XRT
  • WBI
  • Behavioral Dietary Intervention
  • Compliance Monitoring
  • Exercise Intervention
Breakdown of trials Mehmet S. Copur has run
Breast Cancer
Fallopian Tube Carcinoma
Ovarian Cancer
Peritoneal Serous Adenocarcinoma
Fallopian Tube Cancer

Other Doctors you might be interested in

Sharif Khan, MDSaint Francis Hospital / Bon Secours - South Carolina
George A. Petrossian, MDSt. Francis Hospital
David RisebergMercy Medical Center -Weinberg Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehmet S. Copur specialize in?
Mehmet S. Copur focuses on Breast Cancer and Fallopian Tube Carcinoma. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are HER2 positive.
Is Mehmet S. Copur currently recruiting for clinical trials?
Yes, Mehmet S. Copur is currently recruiting for 1 clinical trial in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mehmet S. Copur has studied deeply?
Yes, Mehmet S. Copur has studied treatments such as Regional Nodal XRT, Chestwall XRT, WBI.
What is the best way to schedule an appointment with Mehmet S. Copur?
Apply for one of the trials that Mehmet S. Copur is conducting.
What is the office address of Mehmet S. Copur?
The office of Mehmet S. Copur is located at: Bethesda North Hospital, Cincinnati, Ohio 45242 United States. This is the address for their practice at the Bethesda North Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top